Cargando…

Cathepsin B trafficking in thyroid carcinoma cells

BACKGROUND: The cysteine peptidase cathepsin B is important in thyroid physiology by being involved in prohormone processing initiated in the follicle lumen and completed in endo-lysosomal compartments. However, cathepsin B has also been localized to the extrafollicular space in thyroid cancer tissu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tedelind, Sofia, Jordans, Silvia, Resemann, Henrike, Blum, Galia, Bogyo, Matthew, Führer, Dagmar, Brix, Klaudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155108/
https://www.ncbi.nlm.nih.gov/pubmed/21835049
http://dx.doi.org/10.1186/1756-6614-4-S1-S2
_version_ 1782210079488999424
author Tedelind, Sofia
Jordans, Silvia
Resemann, Henrike
Blum, Galia
Bogyo, Matthew
Führer, Dagmar
Brix, Klaudia
author_facet Tedelind, Sofia
Jordans, Silvia
Resemann, Henrike
Blum, Galia
Bogyo, Matthew
Führer, Dagmar
Brix, Klaudia
author_sort Tedelind, Sofia
collection PubMed
description BACKGROUND: The cysteine peptidase cathepsin B is important in thyroid physiology by being involved in prohormone processing initiated in the follicle lumen and completed in endo-lysosomal compartments. However, cathepsin B has also been localized to the extrafollicular space in thyroid cancer tissue, and is therefore suggested to promote invasiveness and metastasis in thyroid carcinomas through e.g. extracellular matrix degradation. METHODS: Transport of cathepsin B in normal thyroid epithelial and carcinoma cells was investigated through immunolocalization of endogenous cathepsin B in combination with probing protease activity. Transport analyses of cathepsin B-eGFP and its active-site mutant counterpart cathepsin B-C29A-eGFP were used to test whether intrinsic sequences of a protease influence its trafficking. RESULTS: Our approach employing activity based probes, which distinguish between active and inactive cysteine proteases, demonstrated that both eGFP-tagged normal and active-site mutated cathepsin B chimeras reached the endo-lysosomal compartments of thyroid epithelial cells, thereby ruling out alterations of sorting signals by mutagenesis of the active-site cysteine. Analysis of chimeric protein trafficking further showed that GFP-tagged cathepsin B was transported to the expected compartments, i.e. endoplasmic reticulum, Golgi apparatus and endo-lysosomes of normal and thyroid carcinoma cell lines. However, the active-site mutated cathepsin B chimera was mostly retained in the endoplasmic reticulum and Golgi of KTC-1 and HTh7 cells. Hence the latter, as the least polarized of the three carcinoma cell lines analyzed, exhibited severe transport defects in that it retained chimeras in pre-endolysosomal compartments. Furthermore, secretion of endogenous cathepsin B and of other cysteine peptidases, which occurs at the apical pole of normal thyroid epithelial cells, was most prominent and occurred in a non-directed fashion in thyroid carcinoma cells. CONCLUSIONS: Transport of endogenous and eGFP-tagged active and inactive cathepsin B in the cultured thyroid carcinoma cells reflected the distribution patterns of this protease in thyroid carcinoma tissue. Hence, our studies showed that sub-cellular localization of proteolysis is a crucial step in regulation of tissue homeostasis. We conclude that any interference with protease trafficking resulting in altered regulation of proteolytic events leads to, or is a consequence of the onset and progression of thyroid cancer.
format Online
Article
Text
id pubmed-3155108
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31551082011-08-13 Cathepsin B trafficking in thyroid carcinoma cells Tedelind, Sofia Jordans, Silvia Resemann, Henrike Blum, Galia Bogyo, Matthew Führer, Dagmar Brix, Klaudia Thyroid Res Research BACKGROUND: The cysteine peptidase cathepsin B is important in thyroid physiology by being involved in prohormone processing initiated in the follicle lumen and completed in endo-lysosomal compartments. However, cathepsin B has also been localized to the extrafollicular space in thyroid cancer tissue, and is therefore suggested to promote invasiveness and metastasis in thyroid carcinomas through e.g. extracellular matrix degradation. METHODS: Transport of cathepsin B in normal thyroid epithelial and carcinoma cells was investigated through immunolocalization of endogenous cathepsin B in combination with probing protease activity. Transport analyses of cathepsin B-eGFP and its active-site mutant counterpart cathepsin B-C29A-eGFP were used to test whether intrinsic sequences of a protease influence its trafficking. RESULTS: Our approach employing activity based probes, which distinguish between active and inactive cysteine proteases, demonstrated that both eGFP-tagged normal and active-site mutated cathepsin B chimeras reached the endo-lysosomal compartments of thyroid epithelial cells, thereby ruling out alterations of sorting signals by mutagenesis of the active-site cysteine. Analysis of chimeric protein trafficking further showed that GFP-tagged cathepsin B was transported to the expected compartments, i.e. endoplasmic reticulum, Golgi apparatus and endo-lysosomes of normal and thyroid carcinoma cell lines. However, the active-site mutated cathepsin B chimera was mostly retained in the endoplasmic reticulum and Golgi of KTC-1 and HTh7 cells. Hence the latter, as the least polarized of the three carcinoma cell lines analyzed, exhibited severe transport defects in that it retained chimeras in pre-endolysosomal compartments. Furthermore, secretion of endogenous cathepsin B and of other cysteine peptidases, which occurs at the apical pole of normal thyroid epithelial cells, was most prominent and occurred in a non-directed fashion in thyroid carcinoma cells. CONCLUSIONS: Transport of endogenous and eGFP-tagged active and inactive cathepsin B in the cultured thyroid carcinoma cells reflected the distribution patterns of this protease in thyroid carcinoma tissue. Hence, our studies showed that sub-cellular localization of proteolysis is a crucial step in regulation of tissue homeostasis. We conclude that any interference with protease trafficking resulting in altered regulation of proteolytic events leads to, or is a consequence of the onset and progression of thyroid cancer. BioMed Central 2011-08-03 /pmc/articles/PMC3155108/ /pubmed/21835049 http://dx.doi.org/10.1186/1756-6614-4-S1-S2 Text en Copyright ©2011 Tedelind et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Tedelind, Sofia
Jordans, Silvia
Resemann, Henrike
Blum, Galia
Bogyo, Matthew
Führer, Dagmar
Brix, Klaudia
Cathepsin B trafficking in thyroid carcinoma cells
title Cathepsin B trafficking in thyroid carcinoma cells
title_full Cathepsin B trafficking in thyroid carcinoma cells
title_fullStr Cathepsin B trafficking in thyroid carcinoma cells
title_full_unstemmed Cathepsin B trafficking in thyroid carcinoma cells
title_short Cathepsin B trafficking in thyroid carcinoma cells
title_sort cathepsin b trafficking in thyroid carcinoma cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155108/
https://www.ncbi.nlm.nih.gov/pubmed/21835049
http://dx.doi.org/10.1186/1756-6614-4-S1-S2
work_keys_str_mv AT tedelindsofia cathepsinbtraffickinginthyroidcarcinomacells
AT jordanssilvia cathepsinbtraffickinginthyroidcarcinomacells
AT resemannhenrike cathepsinbtraffickinginthyroidcarcinomacells
AT blumgalia cathepsinbtraffickinginthyroidcarcinomacells
AT bogyomatthew cathepsinbtraffickinginthyroidcarcinomacells
AT fuhrerdagmar cathepsinbtraffickinginthyroidcarcinomacells
AT brixklaudia cathepsinbtraffickinginthyroidcarcinomacells